The impact of sarcopenic obesity on cancer clinical outcomes
Seminars in Cancer Biology · 2025-09 · 114 · 203-214
DOI: 10.1016/j.semcancer.2025.07.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2025-09. Verfasst von Bahadır Köylü und 3 weiteren Autor:innen. Beteiligte Einrichtung: Koç University School of Medicine, Department of Internal Medicine, Division of Medical Oncology, Istanbul, Turkey. Electronic address: bkoylu@ku.edu…. Hauptthemen laut MEDLINE: Sarcopenia, Obesity, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 82 Literaturangaben.
Abstract (Originalsprache)
Sarcopenic obesity is a distinct clinical condition characterized by the coexistence of excess fat and reduced muscle mass. Although the prevalence of sarcopenic obesity varies depending on the definition used, it is increasingly recognized as a significant health concern, regardless of age and underlying disease. Despite limited understanding of the crosstalk between sarcopenic obesity and cancer, emerging evidence suggests that sarcopenic obesity not only promotes a metabolic and inflammatory environment conducive to cancer progression but also profoundly impacts treatment efficacy, safety, and survival outcomes. This review provides a concise overview of the key aspects of sarcopenic obesity, with a particular focus on its role in the cancer setting. We also assess existing evidence on its influence on oncological outcomes in both early and advanced stages of the various solid tumor types.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Koç University School of Medicine, Department of Internal Medicine, Division of Medical Oncology, Istanbul, Turkey. Electronic address: bkoylu@ku.edu.tr.
- Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Department of Internal Medicine, Division of Endocrinology, Metabolism and Diabetes, Istanbul, Turkey. Electronic address: drcemsulu@yahoo.com.
- Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Department of Internal Medicine, Division of Endocrinology, Metabolism and Diabetes, Istanbul, Turkey. Electronic address: vdyumuk@iuc.edu.tr.
- Koç University School of Medicine, Department of Internal Medicine, Division of Medical Oncology, Istanbul, Turkey. Electronic address: fyumuk@ku.edu.tr.
Zitieren
APA
Köylü, B., Sulu, C., Yumuk, V. D., & Yumuk, P. F. (2025). The impact of sarcopenic obesity on cancer clinical outcomes. Seminars in Cancer Biology, 114, 203-214. https://doi.org/10.1016/j.semcancer.2025.07.002
Vancouver
Köylü B, Sulu C, Yumuk VD, Yumuk PF. The impact of sarcopenic obesity on cancer clinical outcomes. Seminars in Cancer Biology. 2025;114:203-214. doi:10.1016/j.semcancer.2025.07.002
BibTeX
@article{Kyl2025,
author = {Köylü, Bahadır and Sulu, Cem and Yumuk, Volkan Demirhan and Yumuk, Perran Fulden},
title = {The impact of sarcopenic obesity on cancer clinical outcomes},
journal = {Seminars in Cancer Biology},
year = {2025},
volume = {114},
pages = {203--214},
doi = {10.1016/j.semcancer.2025.07.002}
}
EUVIMED